A Functional Melanocortin System May Be Required for Chronic CNS-Mediated Antidiabetic and Cardiovascular Actions of Leptin

OBJECTIVE We recently showed that leptin has powerful central nervous system (CNS)-mediated antidiabetic and cardiovascular actions. This study tested whether the CNS melanocortin system mediates these actions of leptin in diabetic rats. RESEARCH DESIGN AND METHODS A cannula was placed in the lateral ventricle of Sprague-Dawley rats for intracerebroventricular infusions, and arterial and venous catheters were implanted to measure mean arterial pressure (MAP) and heart rate 24 h/day and for intravenous infusions. After recovery from surgery for 8 days, rats were injected with streptozotocin (STZ), and 5 days later, either saline or the melanocortin 3 and 4 receptor (MC3/4R) antagonist SHU-9119 (1 nmol/h) was infused intracerebroventricularly for 17 days. Seven days after starting the antagonist, leptin (0.62 μg/h) was added to the intracerebroventricular infusion for 10 days. Another group of diabetic rats was infused with the MC3/4R agonist MTII (10 ng/h i.c.v.) for 12 days, followed by 7 days at 50 ng/h. RESULTS Induction of diabetes caused hyperphagia, hyperglycemia, and decreases in heart rate (−76 bpm) and MAP (−7 mmHg). Leptin restored appetite, blood glucose, heart rate, and MAP back to pre-diabetic values in vehicle-treated rats, whereas it had no effect in SHU-9119–treated rats. MTII infusions transiently reduced blood glucose and raised heart rate and MAP, which returned to diabetic values 5–7 days after starting the infusion. CONCLUSIONS Although a functional melanocortin system is necessary for the CNS-mediated antidiabetic and cardiovascular actions of leptin, chronic MC3/4R activation is apparently not sufficient to mimic these actions of leptin that may involve interactions of multiple pathways.

• Publication year

  2009

• Venue

  Diabetes

• Publication date

  2009-06-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2337/db08-1221PMID 19491210PMCID 2712780
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropeptides responding to leptin.

  2009cited by this paper
• Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats.

  2008cited by this paper
• Melanocortin-4 Receptor Mediates Chronic Cardiovascular and Metabolic Actions of Leptin

  2006cited by this paper
• Does Obesity Induce Resistance to the Long-Term Cardiovascular and Metabolic Actions of Melanocortin 3/4 Receptor Activation?

  2006cited by this paper
• Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity.

  2006cited by this paper
• Role of Hypothalamic Melanocortin 3/4-Receptors in Mediating Chronic Cardiovascular, Renal, and Metabolic Actions of Leptin

  2004cited by this paper
• Role of Adrenergic Activity in Pressor Responses to Chronic Melanocortin Receptor Activation

  2004cited by this paper
• Role of Melanocortin-4 Receptors in Mediating Renal Sympathoactivation to Leptin and Insulin

  2003cited by this paper
• Hypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function

  2003influential reference
• Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity

  2002cited by this paper
• Central melanocortin receptors regulate insulin action.

  2001cited by this paper
• Hypothalamic, Metabolic, and Behavioral Responses to Pharmacological Inhibition of CNS Melanocortin Signaling in Rats

  2001cited by this paper
• Central nervous system control of food intake

  2000cited by this paper
• Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothalamic injection of leptin in rats.

  1999cited by this paper
• Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice.

  1999cited by this paper
• Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic.

  1999cited by this paper
• Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system.

  1998cited by this paper
• Chronic leptin infusion increases arterial pressure.

  1998cited by this paper
• Intracerebroventricular Leptin Regulates Hepatic but Not Peripheral Glucose Fluxes*

  1998cited by this paper
• Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes.

  1997cited by this paper
• Intracerebroventricular Leptin Increases Lumbar and Renal Sympathetic Nerve Activity and Blood Pressure in Normal Rats

  1997cited by this paper
• Melanocortin receptors in leptin effects

  1997cited by this paper
• Receptor-mediated regional sympathetic nerve activation by leptin.

  1997cited by this paper
• Sympathetic and cardiorenal actions of leptin.

  1997cited by this paper
• Post-translational processing of proopiomelanocortin in the pituitary and in the brain.

  1997cited by this paper
• Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein.

  1997cited by this paper
• Role of leptin in fat regulation

  1996cited by this paper
• Positional cloning of the mouse obese gene and its human homologue

  1995cited by this paper
• Regulatory mechanism of the ventromedial hypothalamus in enhancing glucose uptake in skeletal muscles.

  1994cited by this paper
• Positional cloning of the mouse obese gene and its human homologue

  1994cited by this paper
• Neuropeptide Y release from the paraventricular nucleus increases in association with hyperphagia in streptozotocin-induced diabetic rats.

  1992cited by this paper
• Diabetes

  1894cited by this paper

• Sex differences in weight gain, blood pressure control, and responses to melanocortin-4 receptor antagonism in offspring from lean and obese parents.

  2023cites this paper
• Epiregulin as an Alternative Ligand for Leptin Receptor Alleviates Glucose Intolerance without Change in Obesity

  2022cites this paper
• Chronic Antidiabetic Actions of Leptin: Evidence From Parabiosis Studies for a CNS-Derived Circulating Antidiabetic Factor

  2021cites this paper
• A neural basis for brain leptin action on reducing type 1 diabetic hyperglycemia

  2021cites this paper
• Biological Pathways in Adolescent Aortic Stiffness

  2021cites this paper
• The MC4R p.Ile269Asn mutation confers a high risk for type 2 diabetes in the Mexican population via obesity dependent and independent effects

  2021cites this paper
• Neuronal control of peripheral nutrient partitioning

  2020cites this paper
• CNS Regulation of Glucose Homeostasis: Role of the Leptin-Melanocortin System

  2020cites this paper
• Chronic CNS-mediated cardiometabolic actions of leptin: potential role of sex differences.

  2020cites this paper
• Ovarian failure induced by 4‐vinylcyclohexene diepoxide worsens the autonomic cardiovascular response to chronic unpredictable stress in rats

  2019cites this paper
• Impact of leptin deficiency compared to neuronal specific leptin receptor deletion on cardiometabolic regulation.

  2019cites this paper
• Melanocortin-4 Receptors and Sympathetic Nervous System Activation in Hypertension

  2019cites this paper
• Control of appetite, blood glucose, and blood pressure during melanocortin-4 receptor activation in normoglycemic and diabetic NPY-deficient mice.

  2018cites this paper
• Lorcaserin and metabolic disease: weight‐loss dependent and independent effects

  2018cites this paper
• Leptin reverses hyperglycemia and hyperphagia in insulin deficient diabetic rats by pituitary-independent central nervous system actions

  2017cites this paper
• Role of autonomic nervous system in chronic CNS-mediated antidiabetic action of leptin.

  2017cites this paper
• Central leptin action on euglycemia restoration in type 1 diabetes: Restraining responses normally induced by fasting?

  2017cites this paper
• The role of leptin in diabetes: metabolic effects

  2016cites this paper
• The Role of the Melanocortin System in Metabolic Disease: New Developments and Advances

  2016cites this paper
• Adipose- and muscle-derived Wnts trigger pancreatic β-cell adaptation to systemic insulin resistance

  2016cites this paper
• Circulating Adipokines and Vascular Function: Cross-Sectional Associations in a Community-Based Cohort.

  2016cites this paper
• Activation of the brain melanocortin system is required for leptin‐induced modulation of chemorespiratory function

  2015cites this paper
• Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases

  2015cites this paper
• Leptin Is Required for Glucose Homeostasis after Roux-en-Y Gastric Bypass in Mice

  2015cites this paper
• Brain-mediated antidiabetic, anorexic, and cardiovascular actions of leptin require melanocortin-4 receptor signaling.

  2015cites this paper
• Control of respiratory and cardiovascular functions by leptin.

  2015cites this paper
• Leptin induces fasting hypoglycaemia in a mouse model of diabetes through the depletion of glycerol

  2015cites this paper
• Neural melanocortin receptors in obesity and related metabolic disorders.

  2014cites this paper
• Hypothalamic agouti-related peptide neurons and the central melanocortin system are crucial mediators of leptin's antidiabetic actions.

  2014cites this paper
• Role of melanocortin signaling in neuroendocrine and metabolic actions of leptin in male rats with uncontrolled diabetes.

  2014cites this paper
• Role of Proopiomelanocortin Neuron Stat3 in Regulating Arterial Pressure and Mediating the Chronic Effects of Leptin

  2013cites this paper
• Does chronic leptin treatment decrease glucagon responsiveness in STZ-induced type 1 diabetic rats?

  2013influential citation
• FGF19 action in the brain induces insulin-independent glucose lowering.

  2013cites this paper
• Leptin action in the ventromedial hypothalamic nucleus is sufficient, but not necessary, to normalize diabetic hyperglycemia.

  2013cites this paper
• Central leptin replacement enhances chemorespiratory responses in leptin-deficient mice independent of changes in body weight

  2012cites this paper
• Centrally acting leptin induces a resuscitating effect in haemorrhagic shock in rats.

  2012cites this paper
• Leptin, diabetes, and the brain

  2012cites this paper
• Leptin revisited: its mechanism of action and potential for treating diabetes

  2012cites this paper
• The role of leptin in glucose homeostasis

  2012cites this paper
• Systemic But Not Central Nervous System Nitric Oxide Synthase Inhibition Exacerbates the Hypertensive Effects of Chronic Melanocortin-3/4 Receptor Activation

  2011cites this paper
• Adiposity, leptin and stress reactivity in humans

  2011cites this paper
• Control of Blood Pressure, Appetite, and Glucose by Leptin in Mice Lacking Leptin Receptors in Proopiomelanocortin Neurons

  2011cites this paper
• Chronic blood pressure and appetite responses to central leptin infusion in rats fed a high fat diet

  2011cites this paper
• Current literature in diabetes

  2010cites this paper
• Immunohistochemical Localization of the Melanocortin-4 Receptor (MC4R) in the Colon Myenteric Plexus

  2010cites this paper
• The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.

  2010cites this paper
• International Journal of Nephrology and Renovascular Disease Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Dovepress Manifestation of Renal Disease in Obesity: Pathophysiology of Obesity-related Dysfunction of the Kidney

  year unknowncites this paper